share_log

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Klausner Richard

SEC ·  Jun 18 04:24
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more